MoneyWorks4Me

Parabolic Drugs informs about compliance certificate

30 Oct 2018 Evaluate

Pursuant to Regulation 40 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parabolic Drugs has informed about Compliance Report on Transfer or Transmission or Transposition of Securities of the Company for the Quarter/ Half Year ended on 30th September, 2018.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..